Sequenom Increases Expected Billings for MaterniT21 Plus to 40,000 in 2012
April 16, 2012
Sequenom Increases Expected Billings for MaterniT21 Plus to 40,000 in 2012
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Sequenom Eyes $100M in Private Notes Offering
September 10, 2012 / GenomeWeb Daily News - Sequenom Inks Deal with MultiPlan to Include MaterniT21 Plus Test
April 19, 2012 / GenomeWeb Daily News - Non-invasive T21 Testing Space Abuzz as Firms Jockey for Share of $1B Market, Battle over IP
April 11, 2012 / GenomeWeb Daily News - Helicos Sells Certain MDx IP to Sequenom for $1.3M, Warns of Potential Bankruptcy
April 11, 2012 / GenomeWeb Daily News - Verinata Licenses Quake Patent, Setting Stage for IP Tussle with Sequenom
September 7, 2011 / Clinical Sequencing News